Genomic and genetic alterations for these RB cases are summarized in Figure 4, showing RB signatures, including RB-SCNAs and/or RB1 SNVs that were identified in 10 (90.1%) AH samples and nine tumor samples (81.8%). Here, RB1 is linked to neoplasm.